Organigram Holdings Inc.

How Much Do Canadians Spend On Marijuana? A Look At Third Quarter 2023 Sales Data
Cannabis Vape, Pre-Roll Market Soars: Canada Sees Double-Digit Growth in Q3 2023
Organigram Strives For 'High Potency Cannabinoid' With $6M Phylos Investment
Cannabis Vape, Pre-Roll Market Soars: Canada Sees Double-Digit Growth in Q3 2023
Organigram Strives For 'High Potency Cannabinoid' With $6M Phylos Investment
Tilray, Decibel, Village Farms Poised For Success? Analyst Examines Canada's Marijuana Market
Sundial, Canopy Growth And More: Analyst Examines The Race For The US Cannabis Market

Organigram Holdings Inc. Recent News

EXCLUSIVE: Key Insights And 4 Predictions On Cannabis Sector Equity Research For 2024
In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months.
Enjoy Summer Solstice With The Hottest New Cannabis Products: Premium Flower Strains, Infused Gummies, And Pre-Rolls
Discover the latest cannabis products in this exclusive round-up from Benzinga. We've curated a diverse selection of new launches by cannabis operators, catering to both connoisseurs and casual enthusiasts.
Organigram In Search Of Investors And Enhanced Marketability: What's At Stake? What's Their Plan?
Organigram Holdings (NASDAQ: OGI), a major licensed producer of cannabis and cannabis-derived products in Canada, announced plans to consolidate its shares on a 4-to-1 basis.
Organigram Takes On Health Canada In Battle For Cannabis Ingestible Extracts Freedom
In a challenge to Health Canada's recent decision to restrict the sale of cannabis extracts that go beyond the federal 10mg THC packaging limit, cannabis producer Organigram Holdings Inc. (NASDAQ:
Revolutionizing Sustainable Cannabis Vaping, Greentank Technologies Closes $16.5M Series B
Greentank Technologies, a business-to-business technology company specializing in the design, development and manufacture of precision-made vaporization hardware and atomization technology, secured $16.5 million in Series B funding to accelerate growth in sustainable cannabis vaping tech.
OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says
On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,
Earnings Update: Organigram, Grow Generation, KushCo
Organigram Plans To Ramp Up Staff Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) posted financial results for the first quarter of fiscal 2021.
Earnings Roundup: iAnthus, Can-Fite, Organigram, Bluma Wellness, Auxly
iAnthus Touts 82% YoY Revenue Growth, Names Interim COO
Papa & Barkley Expands Edibles Offering With Releaf Chocolates
Cannabis wellness company Papa & Barkley has introduced Releaf Chocolates, a new line of THC-rich edibles that contain Fair Trade Certified ingredients.
Organigram Invests In Hyasynth Biologicals, Parts Ways With Executives
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has invested an additional $2.5 million in a private biotechnology company Hyasynth Biologicals Inc.